Be The Match BioTherapies
Adam Gallagher has over 20 years of experience in the biotechnology and research sectors. Currently serving as an Account Manager and Client Engagement professional at NMDP BioTherapies since August 2019, Adam previously held multiple positions at R&D Systems, including Advanced Research Associate, Senior Research Associate, and Research Associate III from August 2012 to August 2019. Adam began the career as a Research Associate in 2002 at R & D Systems, Inc., progressing through various roles, including Research Associate II at Research & Diagnostic Systems Inc. from 2007 to 2012. Adam earned a degree from Saint John's University between 1997 and 2001.
Be The Match BioTherapies
Be The Match BioTherapies® partners with cell and gene therapy companies to save lives through autologous and allogeneic cellular therapy. We are the only cell and gene therapy solutions provider with customizable services to support the entire end-to-end cell therapy supply chain. As part of the National Marrow Donor Program®(NMDP)/Be The Match®, Be The Match BioTherapies has sourced, collected and delivered cells from more than 100,000 volunteer allogeneic donors around the world for time-critical cellular therapies. We have extensive experience providing cellular source material consented for research, clinical and commercial use. Throughout the past 35+ years, Be The Match BioTherapies has developed and continually enhanced their cell collection network and proven cell therapy supply chain infrastructure. The teams are responsible for more than 6,500 time-sensitive cell therapy shipments per year. Through the CIBMTR® (Center for International Blood and Marrow Transplant Research®), Be The Match BioTherapies provides long-term follow-up tracking for the first two FDA-approved CAR-T therapies. We ask that you please review and follow our Community Guidelines to ensure responsible and respectful conversations: http://bit.ly/2Apu7Ja